Alavert Allergy
NDC Package 0573-2621-13

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Alavert Allergy is a . Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0573-2621 and is authorized under FDA application NDA021375.

Identification & Billing

NDC Package Code
0573-2621-13
Package Description
12 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00573262113

Clinical Specifications

Proprietary Name
Alavert Allergy
Dosage Form
-

Regulatory & Marketing

Labeler Name
Haleon Us Holdings Llc
FDA Application #
NDA021375
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-19-2002
End Marketing Date
08-31-2023
Listing Expiration
08-31-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0573-2621). Click a package code to view its specific billing and regulatory data.

18 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
60 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0573-2621-13 identifies a specific commercial package of 12 blister pack in 1 carton / 1 tablet, orally disintegrating in 1 blister pack of Alavert Allergy, labeled by Haleon Us Holdings Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Haleon Us Holdings Llc on December 19, 2002. The current certification is valid through August 31, 2023.

How is this Haleon Us Holdings Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00573262113. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0573-2621-13
11-Digit CMS (5-4-2)
00573-2621-13

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.